HYDROXYLAMINDERIVATE

European patent · EP1692096 · Deleted

Register entry

Publication number
EP1692096
Application number
EP04803725
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 10, 2004
Published
Aug 23, 2006
Granted
Apr 3, 2013
Deleted
Jul 23, 2022
Reason
Annual fee unpaid
IPC classes
C07C 239/12 (2006.01)
C07C 239/20 (2006.01)
A61K 31/13 (2006.01)
A61P 25/00 (2006.01)
Priority
EP 03028441 11.12.2003
PCT application
PCT/EP2004/014077 10.12.2004
PCT publication
WO2005/058800 30.06.2005
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 23, 2022

    Deleted, fee unpaid

    Published in Swissreg on 23.07.2022

  2. May 17, 2013

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 17.05.2013

  3. Apr 3, 2013

    Granted

    Published in Swissreg on 03.04.2013

Parties

Holder

Newron Pharmaceuticals S.p.A.

Via L. Ariosto, 21, 20091 Bresso (MI), IT

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

CACCIA, Carla

I-21010 Cardano Al Campo, IT

GIROLA, Laura

I-21040 Gerenzano, IT

KALTOFEN, Petra, Karin

I-20144 Milano, IT

LOSI, Daniele

I-22069 Rovellasca, IT

SALVATI, Patricia

I-20020 Arese, IT

SELVA, Enrico

I-27027 Gropello Cairoli, IT

THALER, Florian

I-39012 Merano, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.